ALLR vs RJF · P/E 0.0, rev $25.0K vs rev $15.91B
Allarity Therapeutics Inc (ALLR) versus RJF (RJF) — a side-by-side from cached financials, not a winner call.
Allarity Therapeutics Inc (ALLR) is a biotechnology company listed on US.
RJF (RJF) common stock.
Latest reported ALLR revenue for 2026-06-30 was $25.0K. Net income was -$6.2M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. ALLR currently screens at market cap $15.1M and trailing P/E 0.0.
Latest reported RJF revenue for 2025-09-30 was $15.91B. Net income was $2.13B. Revenue was up 6.6% from 2024-09-30 to 2025-09-30. RJF currently screens at market cap $0.
ALLR currently screens at market cap $15.1M and trailing P/E 0.0. RJF currently screens at market cap $0.
Not investment advice. Open the ALLR and RJF stock pages for the full models.
Not investment advice.